Lataa...
Systemic sclerosis medications and risk of scleroderma renal crisis
BACKGROUND: Scleroderma Renal Crisis (SRC) is associated with significant morbidity and mortality. While prednisone is strongly associated with SRC, there are no previous large cohort studies that have evaluated ace inhibitor (ACEi) calcium channel blocker (CCB), angiotensin receptor blocker (ARB),...
Tallennettuna:
| Julkaisussa: | BMC Nephrol |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6659266/ https://ncbi.nlm.nih.gov/pubmed/31345158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1467-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|